Photo from Robert Miller/LinkedIn
Mar 14, 2024, 16:35
Robert Miller: Always great to talk to Jeff about the vision and journey of CancerLinQ, founded by ASCO and now an initiative of ConcertAI
Robert Miller, Chief Medical Science Officer at CancerLinQ, shared the following post by CancerLinQ on LinkedIn, adding the following:
“Always great to talk to Jeff about the vision and journey of CancerLinQ, founded by ASCO and now an initiative of ConcertAI. We discussed how we use data and technology to improve cancer care quality, some of the new initiatives including support for ASCO Certified, and ultimately how CancerLinQ will advance our shared goal of having more patients benefit from the promise of precision oncology.”
Quoting CancerLinQ’s post:
“Don’t miss this episode with our own Dr. Robert Miller discussing the role we play in oncology today!”
Source: Robert Miller/LinkedIn and CancerLinQ/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43